The Journal of Immunology · 2011 · 74 citations · 39 references
Life SciencesImmunologyPharmacotherapyCancer ImmunologyCellular ImmunologyImmunotherapyCell-mediated ImmunityCytokine BiologyDendritic Cell BiologyInnate Immune ModulationMultiple MyelomaT Cell Responses To TumorsCd8 Positive T CellsInnate Immune Cell FunctionInnate Immune EffectorsMultiple Myeloma ChemotherapyMultiple Myeloma TherapyMultiple Myeloma TreatmentMyeloma PathogenesisRefractory Multiple Myeloma
Vγ9Vδ2 T cells play a major role as effector cells of innate immune responses against microbes, stressed cells, and tumor cells. They constitute <5% of PBLs but can be expanded by zoledronic acid (ZA)-treated monocytes or dendritic cells (DC). Much less is known about their ability to act as cellular adjuvants bridging innate and adaptive immunity, especially in patients with cancer. We have addressed this issue in multiple myeloma (MM), a prototypic disease with several immune dysfunctions that also affect γδ T cells and DC. ZA-treated MM DC were highly effective in activating autologous γδ T cells, even in patients refractory to stimulation with ZA-treated monocytes. ZA inhibited the mevalonate pathway of MM DC and induced the intracellular accumulation and release into the supernatant of isopentenyl pyrophosphate, a selective γδ T cell activator, in sufficient amounts to induce the proliferation of γδ T cells. Immune responses against the tumor-associated Ag survivin (SRV) by MHC-restricted, SRV-specific CD8(+) αβ T cells were amplified by the concurrent activation of γδ T cells driven by autologous DC copulsed with ZA and SRV-derived peptides. Ancillary to the isopentenyl pyrophosphate-induced γδ T cell proliferation was the mevalonate-independent ZA ability to directly antagonize regulatory T cells and downregulate PD-L2 expression on the DC cell surface. In conclusion, ZA has multiple immune modulatory activities that allow MM DC to effectively handle the concurrent activation of γδ T cells and MHC-restricted CD8(+) αβ antitumor effector T cells.
39
Natural and synthetic non-peptide antigens recognized by human γδ T cells
Yoshimasa Tanaka, Craig T. Morita, Yôko Tanaka et al. · Nature · 1995 · 1K citations
Christopher A. Klebanoff, Luca Gattinoni, Parizad Torabi‐Parizi et al. · Proceedings of the National Academy of Sciences · 2005 · 972 citations · Full text
Life Sciences, Immunology, Oncology +17